Chronic wounds are difficult to treat, with symptoms such as loss of skin tissue around the wound. Once a wound becomes chronic, medical intervention ...
The acquisition of ProgenaMatrix and revyve Antimicrobial Wound Gel reflects the Company's continued commitment to building a diverse portfolio of complementary wound care products that enable BioStem ...
BioStem expects to finalize definitive agreements within 60 days following customary due diligence. The transaction is subject to regulatory approvals and Board consent. BioStem and ProgenaCare will ...
Organogenesis Pleased to Lead Collaborative Effort to Support Data-Driven Policy on Local Coverage DeterminationCANTON, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ORGO), a leading regenerative ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...